NPI: 1164475711 · WARSAW, IN 46580 · General Acute Care Hospital · NPI assigned 05/17/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/17/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,672 | $312K |
| 2019 | 20,509 | $641K |
| 2020 | 19,949 | $838K |
| 2021 | 34,615 | $1.65M |
| 2022 | 50,076 | $2.43M |
| 2023 | 48,963 | $2.36M |
| 2024 | 33,105 | $1.73M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 16,389 | 12,336 | $2.42M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,624 | 11,924 | $2.19M |
| 71045 | Radiologic examination, chest; single view | 7,078 | 5,231 | $889K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,780 | 4,234 | $735K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,863 | 1,311 | $722K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,245 | 5,986 | $470K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,677 | 4,443 | $331K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,483 | 2,552 | $258K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,476 | 1,797 | $232K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7,362 | 5,806 | $182K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 152 | 110 | $143K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 763 | 542 | $117K |
| 80053 | Comprehensive metabolic panel | 20,248 | 14,810 | $115K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,207 | 3,171 | $108K |
| 80050 | General health panel | 968 | 792 | $104K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,027 | 874 | $100K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,066 | 3,584 | $97K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 24,116 | 17,112 | $94K |
| 71046 | Radiologic examination, chest; 2 views | 820 | 676 | $74K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,260 | 4,064 | $63K |
| 84484 | 7,605 | 4,594 | $43K | |
| 36415 | Collection of venous blood by venipuncture | 21,774 | 15,380 | $39K |
| 72125 | Computed tomography, cervical spine; without contrast material | 221 | 144 | $33K |
| 29581 | 739 | 156 | $33K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 951 | 729 | $30K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 76 | 57 | $26K |
| 29580 | 661 | 118 | $23K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,497 | 1,855 | $23K |
| 87430 | 1,545 | 1,298 | $18K | |
| 83690 | 5,622 | 4,127 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 858 | 726 | $16K |
| 81001 | 7,612 | 5,634 | $13K | |
| 80061 | Lipid panel | 1,619 | 1,338 | $12K |
| 83605 | 1,995 | 1,250 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,451 | 2,637 | $11K |
| 99221 | 38 | 27 | $10K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 254 | 198 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | 923 | 763 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 257 | 212 | $8K |
| 87040 | 1,720 | 702 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,409 | 1,148 | $7K |
| 72131 | 35 | 25 | $6K | |
| 87081 | 1,130 | 954 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 406 | 330 | $6K |
| 83880 | 300 | 217 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 21 | 15 | $5K |
| 81003 | 4,083 | 3,063 | $5K | |
| 82607 | 432 | 358 | $4K | |
| 95816 | 13 | 12 | $4K | |
| 85379 | 677 | 512 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 138 | 115 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 140 | 117 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 140 | 117 | $4K |
| 74018 | 31 | 24 | $4K | |
| 85730 | 1,367 | 958 | $4K | |
| 99218 | 19 | 12 | $4K | |
| 85610 | 1,675 | 1,177 | $3K | |
| 84703 | 635 | 484 | $3K | |
| 73630 | 120 | 78 | $3K | |
| 82077 | 221 | 177 | $3K | |
| 87807 | 246 | 195 | $3K | |
| 83735 | 880 | 491 | $3K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18 | 13 | $2K |
| 80076 | 1,207 | 899 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 27 | 13 | $2K |
| 84145 | 88 | 66 | $2K | |
| 84450 | 488 | 410 | $2K | |
| 87400 | 118 | 61 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 86 | 69 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 228 | 170 | $879.51 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17 | 17 | $847.63 |
| 81025 | 160 | 115 | $811.72 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 175 | 118 | $801.68 |
| 86803 | 63 | 54 | $682.55 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 14 | 12 | $500.78 |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19 | 12 | $446.59 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 48 | 26 | $444.82 |
| 85027 | 82 | 71 | $362.62 | |
| 84439 | 91 | 68 | $362.02 | |
| 82378 | 14 | 12 | $151.68 | |
| 83615 | 49 | 39 | $147.07 | |
| 82746 | 17 | 12 | $145.54 | |
| 80069 | 36 | 18 | $104.16 | |
| 86850 | 28 | 25 | $102.25 | |
| 87077 | 14 | 12 | $88.88 | |
| 83550 | 13 | 12 | $78.66 | |
| 84550 | 31 | 25 | $78.42 | |
| 83540 | 13 | 12 | $58.23 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,173 | 3,952 | $53.67 |
| 86900 | 28 | 25 | $50.83 | |
| 86901 | 28 | 25 | $50.83 | |
| 82043 | 17 | 12 | $18.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,946 | 2,962 | $0.50 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 63 | 55 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 17 | 13 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,061 | 820 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 708 | 462 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 181 | 134 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 369 | 304 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 14 | 13 | $0.00 |